Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doyeon Hwang

Showing results (71-80 of 181) with videos related to

Pageof 19
Sort By:
Circulation|November 18, 2020
Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: The HOST-REDUCE-POLYTECH-ACS TrialHyo-Soo Kim, Jeehoon Kang, Doyeon Hwang, et al.
International Journal of Cardiology|December 10, 2019
Prognostic impact of diabetes mellitus and index of microcirculatory resistance in patients undergoing fractional flow reserve-guided revascularizationXinyang Hu, Jinlong Zhang, Joo Myung Lee, et al.
Lancet (London, England)|September 4, 2020
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trialHyo-Soo Kim, Jeehoon Kang, Doyeon Hwang, et al.
The American Journal of Cardiology|May 13, 2018
Outcomes in Patients with Diabetes Mellitus According to Insulin Treatment After Percutaneous Coronary Intervention in the Second-Generation Drug-Eluting Stent EraSeung-Hoon Pi, Tae-Min Rhee, Joo Myung Lee, et al.
JACC. Cardiovascular Interventions|April 3, 2017
Diagnostic Performance of Resting and Hyperemic Invasive Physiological Indices to Define Myocardial Ischemia: Validation With <sup>13</sup>N-Ammonia Positron Emission TomographyDoyeon Hwang, Ki-Hyun Jeon, Joo Myung Lee, et al.
JACC. Cardiovascular Interventions|October 4, 2016
Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis of the Korean Multicenter Drug-Eluting Stent RegistryJoo Myung Lee, Jeehoon Kang, Euijae Lee, et al.
JACC. Asia|November 7, 2022
Differences in Plaque Characteristics and Myocardial Mass: Implications for Physiological SignificanceChee Hae Kim, Seokhun Yang, Jinlong Zhang, et al.
JACC. Cardiovascular Interventions|May 26, 2018
Impact of Optimized Procedure-Related Factors in Drug-Eluting Balloon Angioplasty for Treatment of In-Stent RestenosisTae-Min Rhee, Joo Myung Lee, Eun-Seok Shin, et al.
Scientific Reports|April 29, 2021
Non-randomized comparison between revascularization and deferral for intermediate coronary stenosis with abnormal fractional flow reserve and preserved coronary flow reserveDoosup Shin, Joo Myung Lee, Seung Hun Lee, et al.
Korean Circulation Journal|June 21, 2026
2026 Focus Update of the 2021 Korean Society of Myocardial Infarction Expert Consensus Document on Revascularization for Acute Coronary SyndromesSeung Hun Lee, Ki Hong Choi, Doyeon Hwang, et al.
Pageof 19

Showing results (71-80 of 181) with videos related to

Sort By:
Pageof 19
Circulation|November 18, 2020
Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: The HOST-REDUCE-POLYTECH-ACS TrialHyo-Soo Kim, Jeehoon Kang, Doyeon Hwang, et al.
International Journal of Cardiology|December 10, 2019
Prognostic impact of diabetes mellitus and index of microcirculatory resistance in patients undergoing fractional flow reserve-guided revascularizationXinyang Hu, Jinlong Zhang, Joo Myung Lee, et al.
Lancet (London, England)|September 4, 2020
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trialHyo-Soo Kim, Jeehoon Kang, Doyeon Hwang, et al.
The American Journal of Cardiology|May 13, 2018
Outcomes in Patients with Diabetes Mellitus According to Insulin Treatment After Percutaneous Coronary Intervention in the Second-Generation Drug-Eluting Stent EraSeung-Hoon Pi, Tae-Min Rhee, Joo Myung Lee, et al.
JACC. Cardiovascular Interventions|April 3, 2017
Diagnostic Performance of Resting and Hyperemic Invasive Physiological Indices to Define Myocardial Ischemia: Validation With <sup>13</sup>N-Ammonia Positron Emission TomographyDoyeon Hwang, Ki-Hyun Jeon, Joo Myung Lee, et al.
JACC. Cardiovascular Interventions|October 4, 2016
Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis of the Korean Multicenter Drug-Eluting Stent RegistryJoo Myung Lee, Jeehoon Kang, Euijae Lee, et al.
JACC. Asia|November 7, 2022
Differences in Plaque Characteristics and Myocardial Mass: Implications for Physiological SignificanceChee Hae Kim, Seokhun Yang, Jinlong Zhang, et al.
JACC. Cardiovascular Interventions|May 26, 2018
Impact of Optimized Procedure-Related Factors in Drug-Eluting Balloon Angioplasty for Treatment of In-Stent RestenosisTae-Min Rhee, Joo Myung Lee, Eun-Seok Shin, et al.
Scientific Reports|April 29, 2021
Non-randomized comparison between revascularization and deferral for intermediate coronary stenosis with abnormal fractional flow reserve and preserved coronary flow reserveDoosup Shin, Joo Myung Lee, Seung Hun Lee, et al.
Korean Circulation Journal|June 21, 2026
2026 Focus Update of the 2021 Korean Society of Myocardial Infarction Expert Consensus Document on Revascularization for Acute Coronary SyndromesSeung Hun Lee, Ki Hong Choi, Doyeon Hwang, et al.
Pageof 19